Scholar Rock (SRRK)
NASDAQ: SRRK
· Real-Time Price · USD
31.14
-0.99 (-3.08%)
At close: Jun 17, 2025, 3:59 PM
32.02
2.81%
After-hours: Jun 17, 2025, 06:43 PM EDT
-3.08% (1D)
Bid | 24 |
Market Cap | 2.96B |
Revenue (ttm) | n/a |
Net Income (ttm) | -264.16M |
EPS (ttm) | -2.55 |
PE Ratio (ttm) | -12.21 |
Forward PE | -21.01 |
Analyst | Buy |
Ask | 33.36 |
Volume | 544,168 |
Avg. Volume (20D) | 1,267,707 |
Open | 31.72 |
Previous Close | 32.13 |
Day's Range | 30.96 - 31.88 |
52-Week Range | 6.76 - 46.98 |
Beta | 0.30 |
About SRRK
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SRRK
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SRRK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-2.74%
SRRK stock has given up its prior gain. Scholar Ro...
Unlock content with
Pro Subscription
1 month ago
-2.74%
Scholar Rock Holding shares are trading higher following Q1 reported financial results.

3 weeks ago · businesswire.com
Scholar Rock to Present at the Jefferies Global Healthcare ConferenceCAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (...

1 month ago · seekingalpha.com
Scholar Rock Holding Corporation (SRRK) Q1 2025 Earnings Call TranscriptScholar Rock Holding Corporation (NASDAQ:SRRK ) Q1 2025 Earnings Conference Call May 14, 2025 8:15 AM ET Company Participants Rushmie Nofsinger - VP, Corporate Affairs and IR David Hallal - CEO Akshay...